Motilal Oswal
  • SENSEX
    NIFTY 50
Motilal Oswal
Market

10 things you need to know before the opening bell on May 14

Updated : 2019-05-14 08:10:12

Indian shares are likely to open lower on Tuesday as global markets extended losses after China announced plans to impose retaliatory tariffs ranging from 5 percent to 25 percent on 5,140 US products on a target list worth about $60 billion. US equity benchmarks witnessed the worst trading session since January 3. Indian benchmark indices slumped 1 percent in the previous session dragged by pharma, auto and PSU banks. Pharma stocks plunged after more than 40 US states filed a lawsuit against 20 drug companies, including seven Indian firms, alleging drug manufacturers of conspiring to inflate prices of medications. At 06:50 AM, the SGX Nifty was down 61 points, or 0.55 percent, at 11,124, indicating a negative start for the Sensex and the Nifty.

1. Asia: MSCI's broadest index of Asia-Pacific shares outside Japan plummeted by 0.82 percent to 155.76. The Nikkei in Japan fell 1.87 percent while Shanghai dropped 1.2 percent to 2,903.71. South Korea's Kospi was down 1.4 percent to 2,079.01. Hong Kong markets were closed for a holiday on Monday. (Image: Reuters)
1. Asia: MSCI's broadest index of Asia-Pacific shares outside Japan plummeted by 0.82 percent to 155.76. The Nikkei in Japan fell 1.87 percent while Shanghai dropped 1.2 percent to 2,903.71. South Korea's Kospi was down 1.4 percent to 2,079.01. Hong Kong markets were closed for a holiday on Monday. (Image: Reuters)
2. US: The Dow Jones Industrial Average tanked 617.38 points to 25,324.99. The S&P 500 also had its worst day falling 2.4 percent while Nasdaq dropped 3.4 percent- highest one-day loss of the year. (Image: Reuters)
2. US: The Dow Jones Industrial Average tanked 617.38 points to 25,324.99. The S&P 500 also had its worst day falling 2.4 percent while Nasdaq dropped 3.4 percent- highest one-day loss of the year. (Image: Reuters)
3. Markets At Close On Monday: Indian shares ended lower dragged by pharma, auto and PSU bank stocks. The Sensex settled 372 points lower at 37,091, while the Nifty50 lost 131 points to end at 11,148. (Image: Reuters)
3. Markets At Close On Monday: Indian shares ended lower dragged by pharma, auto and PSU bank stocks. The Sensex settled 372 points lower at 37,091, while the Nifty50 lost 131 points to end at 11,148. (Image: Reuters)
4. Crude Oil: The Brent crude futures were at $70.27 a barrel at 0104 GMT, up 6 cents, or 0.1%, from their last close. U.S. West Texas Intermediate (WTI) crude futures were at $61.17 per barrel, up 12 cents, or 0.2%, from their previous settlement. (Image: Reuters)
4. Crude Oil: The Brent crude futures were at $70.27 a barrel at 0104 GMT, up 6 cents, or 0.1%, from their last close. U.S. West Texas Intermediate (WTI) crude futures were at $61.17 per barrel, up 12 cents, or 0.2%, from their previous settlement. (Image: Reuters)
5. Rupee: The Indian rupee ended lower as it slipped 62 paise at 70.53 versus previous close of 69.91. (Image: Reuters)
5. Rupee: The Indian rupee ended lower as it slipped 62 paise at 70.53 versus previous close of 69.91. (Image: Reuters)
6. US Dollar: The dollar index, which tracks the greenback against a basket of its peers, was at 97.30. (Image: Reuters)
6. US Dollar: The dollar index, which tracks the greenback against a basket of its peers, was at 97.30. (Image: Reuters)
7. FIIs & DIIs: Foreign institutional investors (FIIs) sold shares worth Rs 1,056 crore on a net basis in the cash market, while domestic institutional investors (DIIs) bought shares worth Rs 1,058 crore. (Image: Reuters)
7. FIIs & DIIs: Foreign institutional investors (FIIs) sold shares worth Rs 1,056 crore on a net basis in the cash market, while domestic institutional investors (DIIs) bought shares worth Rs 1,058 crore. (Image: Reuters)
8. China Tariffs On US: China said on Monday it would impose higher tariffs on a range of US goods, striking back in its trade war with Washington shortly after US President Donald Trump warned it not to retaliate. China's finance ministry said it plans to set import tariffs ranging from 5 percent to 25 percent on 5,140 US products on a target list worth about $60 billion. It said the tariffs will take effect on June 1. (Image: Reuters)
8. China Tariffs On US: China said on Monday it would impose higher tariffs on a range of US goods, striking back in its trade war with Washington shortly after US President Donald Trump warned it not to retaliate. China's finance ministry said it plans to set import tariffs ranging from 5 percent to 25 percent on 5,140 US products on a target list worth about $60 billion. It said the tariffs will take effect on June 1. (Image: Reuters)
9. April Retail Inflation: Consumer Price Index (CPI) or retail inflation in April 2019 rose to 2.92 percent as against 2.86 percent in March. The data released by the Central Statistics Office (CSO) showed that food inflation was at 1.1 percent in April against 0.3 percent in March on a month-on-month basis. The rise in the April inflation rate is due to the increasing vegetable prices. Food inflation is likely to harden to around 1.5 percent on a year-on-year basis as compared to 0.3 percent in March. (Image: Reuters)
9. April Retail Inflation: Consumer Price Index (CPI) or retail inflation in April 2019 rose to 2.92 percent as against 2.86 percent in March. The data released by the Central Statistics Office (CSO) showed that food inflation was at 1.1 percent in April against 0.3 percent in March on a month-on-month basis. The rise in the April inflation rate is due to the increasing vegetable prices. Food inflation is likely to harden to around 1.5 percent on a year-on-year basis as compared to 0.3 percent in March. (Image: Reuters)
10. US Lawsuit On Indian Pharma: In a fresh blow to generic pharmaceutical companies, more than 40 states in the US have filed a lawsuit alleging drug manufacturers of conspiring to inflate prices of medications. The complaint names 20 pharmaceutical companies, including seven Indian companies. The Indian firms named are Aurobindo, Dr Reddys, Glenmark, Lupin, Wockhardt, Zydus and Sun Pharma’s US arm Taro. The allegation is that these companies colluded to increase prices of drugs, sometimes by over 1,000 percent. (Image: Reuters)
10. US Lawsuit On Indian Pharma: In a fresh blow to generic pharmaceutical companies, more than 40 states in the US have filed a lawsuit alleging drug manufacturers of conspiring to inflate prices of medications. The complaint names 20 pharmaceutical companies, including seven Indian companies. The Indian firms named are Aurobindo, Dr Reddys, Glenmark, Lupin, Wockhardt, Zydus and Sun Pharma’s US arm Taro. The allegation is that these companies colluded to increase prices of drugs, sometimes by over 1,000 percent. (Image: Reuters)
Live TV

Ask Our Experts CNBC TV18